Annamaria Colao
University of Naples Federico II
1014 Papers
6.2K Citations
Annamaria Colao is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 103, co-authored 847 publications. Previous affiliations of Annamaria Colao include Parthenope University of Naples.
Chat about Author
Papers
Systemic complications of acromegaly: epidemiology, pathogenesis, and management.
TL;DR: The most important cause of morbidity and functional disability of this disease is arthropathy, which can be reversed at an initial stage, but not if the disease is left untreated for several years.
Metabolic Syndrome and Risk of Cancer: A systematic review and meta-analysis
TL;DR: Available evidence supports the emerging hypothesis that metabolic syndrome may be associated with the risk of some common cancers; for some cancers, the risk differs betweens sexes, populations, and definitions of metabolic syndrome.
1K
Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement
Beverly M. K. Biller,Ashley B. Grossman,Paul M. Stewart,Shlomo Melmed,Xavier Bertagna,Jérôme Bertherat,Michael Buchfelder,Annamaria Colao,Ad R. M. M. Hermus,Leo J. Hofland,Anne Klibanski,André Lacroix,John R. Lindsay,John Newell-Price,Lynnette K. Nieman,S. Petersenn,Nicoletta Sonino,Günter K. Stalla,Brooke Swearingen,Mary Lee Vance,John A.H. Wass,Marco Boscaro +21 more
TL;DR: Thirty-two leading endocrinologists, clinicians, and neurosurgeons with specific expertise in the management of ACTH-dependent Cushing's syndrome representing nine countries were chosen to address criteria for cure and remission of this disorder.
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas
Felipe F. Casanueva,Mark E. Molitch,Janet A. Schlechte,Roger Abs,Vivien Bonert,Marcello D. Bronstein,Thierry Brue,Paolo Cappabianca,Annamaria Colao,Rudolf Fahlbusch,Hugo L. Fideleff,Moshe Hadani,Paul A. Kelly,David L. Kleinberg,Edward R. Laws,Josef Marek,Maurice F. Scanlon,Luís G. Sobrinho,John Wass,Andrea Giustina +19 more
TL;DR: These guidelines represent the current recommendations on the diagnosis and management of prolactinomas based upon comprehensive analysis and synthesis of all available data.
Advances in the treatment of prolactinomas.
TL;DR: A critical analysis of the efficacy and safety of the various modes of therapy available for the treatment of patients with prolactinomas with an emphasis on challenging situations is provided, a discussion of the data regarding withdrawal of medical therapy, and a foreshadowing of novel approaches to therapy that may become available in the future.